7 results
Causes of Drug-Induced Cardiomyopathies

#DrugInduced #Medications #Cardiomyopathy #Cardiomyopathies #Differential #Causes #Cardiology #Pharmacology
Causes of Drug-Induced ... Cardiomyopathies #DrugInduced ... #Medications #Cardiomyopathy ... Differential #Causes #Cardiology ... #Pharmacology
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
tablets, initial dosing ... INR targets #pharmacology ... overview #review #medications ... #drugs #cardiology
Antiarrhythmic Drugs

CLASS IA
 • Procainamide, Quinidine, Disopyramide
CLASS 1B
 • Lidocaine, Mexiletine
CLASS 2
 • Propranolol, Esmolol
CLASS 4
Antiarrhythmic Drugs ... Antiarrhythmic #Medications ... #Classes #Classification ... #Pharmacology # ... cardiology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... management #algorithm #pharmacology ... #treatment #medications ... #decisionaid #cardiology ... hematology #warfarin #dosing
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
Antiarrhythmic Medications ... Vaughan-Williams Classification ... anti-antiarrhythmic drugs ... #pharmacology # ... cardiology
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
Antiarrhythmic Medications ... Vaughan-Williams Classification ... anti-antiarrhythmic drugs ... #pharmacology # ... cardiology
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Receptor Antagonist Indication ... of Migraines: Dosing ... reported this drug ... #Pharmacology # ... Dosing